The Ensign Group Inc
$ 182.97
0.72%
07 Aug - close price
- Market Cap 10,663,937,000 USD
- Current Price $ 182.97
- High / Low $ 183.28 / 180.95
- Stock P/E 28.63
- Book Value 42.26
- EPS 6.39
- Next Earning Report -
- Dividend Per Share $0.26
- Dividend Yield 0.14 %
- Next Dividend Date -
- ROA 0.05 %
- ROE 0.17 %
- 52 Week High 217.84
- 52 Week Low 141.52
About
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.
Analyst Target Price
$220.00
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-07-27 | 2026-04-30 | 2026-02-04 | 2025-11-03 | 2025-07-24 | 2025-04-29 | 2025-02-05 | 2024-10-24 | 2024-07-25 | 2024-05-01 | 2024-02-01 | 2023-10-25 |
| Reported EPS | 1.72 | 1.85 | 1.82 | 1.64 | 1.59 | 1.37 | 1.49 | 1.39 | 1.32 | 1.3 | 1.28 | 1.2 |
| Estimated EPS | 1.63 | 1.82 | 1.77 | 1.61 | 1.55 | 1.49 | 1.48 | 1.38 | 1.3 | 1.28 | 1.27 | 1.19 |
| Surprise | 0.09 | 0.03 | 0.05 | 0.03 | 0.04 | -0.12 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 |
| Surprise Percentage | 5.5215% | 1.6484% | 2.8249% | 1.8634% | 2.5806% | -8.0537% | 0.6757% | 0.7246% | 1.5385% | 1.5625% | 0.7874% | 0.8403% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Previous Dividend Records
| Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 |
| Amount | $0.065 | $0.065 | $0.065 | $0.0625 | $0.0625 | $0.0625 | $0.0625 | $0.06 | $0.06 | $0.06 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ENSG
2026-08-08 09:11:40
Royal Bank of Canada reduced its stake in The Ensign Group, Inc. (NASDAQ:ENSG) by 9.4% in the first quarter, selling 6,650 shares but still retaining 63,888 shares valued at approximately $12.9 million. Other institutional investors like Baillie Gifford & Co., Norges Bank, and Candriam S.C.A. either increased or initiated positions in the company. The Ensign Group reported strong Q1 earnings with EPS of $1.92, surpassing estimates, and a 16.7% year-over-year revenue increase to $1.44 billion, leading to a "Moderate Buy" consensus rating from analysts with an average price target of $216.25.
2026-08-07 14:11:40
Kaplan Fox & Kilsheimer LLP is investigating The Ensign Group, Inc. (ENSG) for potential securities violations following a Hunterbrook Media report alleging inadequate patient care and data manipulation. The report, titled "Ensign: The Nursing Home Empire Built On Fatal Neglect," caused Ensign's stock to drop over 8% on June 8, 2026. Investors who suffered losses are encouraged to contact Kaplan Fox for more information regarding the investigation.
2026-08-07 14:11:40
Renaissance Technologies LLC acquired a new stake of 21,400 shares in The Ensign Group, Inc. (ENSG) during the first quarter, valued at approximately $4.3 million. This purchase contributes to the 96.12% institutional ownership of ENSG, although some directors recently sold shares under pre-arranged plans. The Ensign Group reported strong Q1 earnings, beating estimates with $1.92 EPS and 16.7% revenue growth, and analysts maintain a "Moderate Buy" rating with an average price target of $216.25.
2026-08-06 19:10:05
Kehoe Law Firm, P.C. is investigating Ensign Group (NASDAQ: ENSG) regarding potential breaches of fiduciary duties by its officers and directors, and whether the company and its shareholders may have been harmed. This investigation follows a report by short seller Muddy Waters Research, which alleged that Ensign engages in a systematic scheme of renting Administrator licenses at approximately 20% of its skilled nursing facilities, potentially amounting to fraud against states, Medicare, and Medicaid. Shareholders are encouraged to contact the firm to learn more about their potential legal rights.
2026-08-06 16:41:19
The Ensign Group (ENSG) reported strong Q2 2026 results with higher revenue and net income, leading to an increased full-year 2026 earnings guidance of US$7.75–US$7.85 per diluted share on US$5.87–US$5.92 billion in revenue. This upgraded outlook, driven by their "roll up" model of acquiring and improving skilled nursing and senior care facilities, suggests management's increased confidence in future growth. Investors should consider how this guidance reinforces the company's investment narrative but also raises expectations and potential risks related to acquisition integration, occupancy, and cost control.
2026-08-05 14:42:10
Kaplan Fox & Kilsheimer LLP has launched an investigation into The Ensign Group, Inc. (NASDAQ: ENSG) following allegations of securities law violations. A report by Hunterbrook Media accused Ensign of delivering inadequate patient care and manipulating quality data, leading to an 8.15% drop in the company's stock price on June 8, 2026. The law firm is seeking investors who suffered losses or have information related to the investigation.
